Colonial River Wealth Management, LLC Recursion Pharmaceuticals, Inc. Transaction History
Colonial River Wealth Management, LLC
- $174 Million
- Q1 2025
A detailed history of Colonial River Wealth Management, LLC transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, Colonial River Wealth Management, LLC holds 10,094 shares of RXRX stock, worth $45,927. This represents 0.03% of its overall portfolio holdings.
Number of Shares
10,094
Previous 10,094
-0.0%
Holding current value
$45,927
Previous $68,000
22.06%
% of portfolio
0.03%
Previous 0.03%
Shares
1 transactions
Others Institutions Holding RXRX
# of Institutions
366Shares Held
286MCall Options Held
3.28MPut Options Held
3.16M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl34.8MShares$158 Million1.99% of portfolio
-
Vanguard Group Inc Valley Forge, PA32.3MShares$147 Million0.0% of portfolio
-
Baillie Gifford & CO24.4MShares$111 Million0.12% of portfolio
-
Black Rock Inc. New York, NY17.3MShares$78.8 Million0.0% of portfolio
-
Softbank Group Corp Minato Ku Tokyo, M014.7MShares$66.7 Million0.27% of portfolio
About RECURSION PHARMACEUTICALS, INC.
- Ticker RXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 180,480,000
- Market Cap $821M
- Description
- Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...